ENDURANT CAPITAL MANAGEMENT LP Reata Pharmaceuticals, Inc. Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$612,000
portfolio value

Reata Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 24.35K shares 612K $25.13 24.35K
Q2 2018 share Decrease -100.00% -25K shares -513K $34.97 0
Q1 2018 share Increase 0.00% 25K shares 513K $20.51 25K